Lymphoma Cancer Antibodies
Lymphomas are the fifth highest diagnosed cancer in the United States, with about 4.8% of new cancer cases classified as either Hodgkin or non-Hodgkin lymphoma, contributing approx. 3.6% of cancer deaths yearly. As of 2012, there were approximately 740,000 people living with lymphoma in the United States. Those diagnosed with lymphoma have a 5 year survival rate of 70% (non-Hodgkin) or 86% (Hodgkin). Over the last 10 years, the new cancer case rate has remained stable and the death rate has not changed significantly either. Biocare Medical is proud to offer key lymphoma antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Non-Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/nhl.html
SEER Cancer Statistics Factsheets: Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/hodg.html